Lima Jordão Horácio da Silva
Faculdade de Saúde Pública, Universidade de São Paulo. Av. Dr. Arnaldo 715, Pinheiros. 01255-000 São Paulo SP Brasil.
Cien Saude Colet. 2017 Jul;22(7):2213-2221. doi: 10.1590/1413-81232017227.02652017.
Since the TRIPS Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights) came into effect, Brazil, like other developing countries, has become more assertive in multilateral negotiations and begun to argue that the present international system of intellectual property should be better adapted to its needs and interests. In doing so, the country has emphasized that intellectual property is not a subject exclusively associated with trade, but also with public health and human rights. This paper discusses the activity of the Brazilian government in multilateral negotiations that involve public health, innovation and intellectual property. The conclusion from looking at Brazil's diplomatic activity in this area is that Brazil has been a protagonist in this debate, seeking solutions that mitigate the adverse effect of the present international intellectual property system on access to drugs, and other medical technologies, in the developing countries.
自《与贸易有关的知识产权协定》(TRIPS协定)生效以来,巴西与其他发展中国家一样,在多边谈判中变得更加坚定,并开始主张当前的国际知识产权体系应更好地适应其需求和利益。在此过程中,该国强调知识产权并非仅与贸易相关的主题,还与公共卫生和人权相关。本文讨论了巴西政府在涉及公共卫生、创新和知识产权的多边谈判中的活动。审视巴西在这一领域的外交活动可得出的结论是,巴西一直是这场辩论的主角,寻求减轻当前国际知识产权体系对发展中国家药品及其他医疗技术获取造成的不利影响的解决方案。